Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 417 (2), 389-392
- https://doi.org/10.1016/0006-8993(87)90471-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patientsAnnals of Neurology, 1986
- Release of Ethanolamine, but Not of Serine or Choline, in Rat Pontine Nuclei on Stimulation of Afferents from the Cortex, In VivoJournal of Neurochemistry, 1986
- Ethanolamine Base‐Exchange Reaction in Rat Brain Microsomal SubfractionsJournal of Neurochemistry, 1986
- N-Methylaspartate-Evoked Liberation of Taurine and Phosphoethanolamine In Vivo: Site of ReleaseJournal of Neurochemistry, 1985
- INCREASED GLYCEROL-3-PHOSPHORYLCHOUNE IN POST-MORTEM ALZHEIMER'S BRAINThe Lancet, 1985
- A Possible Interrelationship Between Extracellular Taurine and Phosphoethanolamine in the HippocampusJournal of Neurochemistry, 1984
- Ethanolamine Accumulation by Photoreceptor Cells of the Rabbit RetinaJournal of Neurochemistry, 1984
- Dihydrokainic acid affects extracellular taurine and phosphoethanolamine levels in the hippocampusNeuroscience Letters, 1983
- BASE‐EXCHANGE REACTIONS FOR THE SYNTHESIS OF PHOSPHOLIPIDS IN NERVOUS TISSUE: THE INCORPORATION OF SERINE AND ETHANOLAMINE INTO THE PHOSPHOLIPIDS OF ISOLATED BRAIN MICROSOMES1,2Journal of Neurochemistry, 1971
- REGIONAL DISTRIBUTION OF AMINO ACIDS IN HUMAN BRAIN OBTAINED AT AUTOPSYJournal of Neurochemistry, 1971